@article{6b161ed8027541c8ac05f432bc3cf9cc,
title = "Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers",
abstract = "High prevalence of tobacco use and low success in quitting remain significant problems for reducing disease burden among HIV-infected persons. This study{\textquoteright}s purpose was to examine participant responsiveness and tobacco dependence treatment adherence and their influences on tobacco abstinence among HIV-infected patients. This non-randomized study included HIV-infected smokers 18 years of age or older, who smoked at least 5 cigarettes per day, and had an interest in quitting smoking in the next 30 days. HIV-infected smokers (n = 247) received a 12-week tobacco dependence treatment intervention that included pharmacotherapy and telephone counseling. Younger age and non-White race were associated with lower adherence to pharmacotherapy. Younger age, non-White race, and increased monthly binge drinking were associated with lower adherence to telephone counseling. High participant responsiveness was associated with adherence to pharmacotherapy, counseling, and abstinence. Development and testing of interventions to improve adherence to evidence-based tobacco dependence treatment is warranted.",
keywords = "Adherence, HIV, Participant responsiveness, Smoking cessation, Tobacco dependence treatment",
author = "Browning, {Kristine K.} and Wewers, {Mary Ellen} and Ferketich, {Amy K.} and Philip Diaz and Koletar, {Susan L.} and Reynolds, {Nancy R.}",
note = "Funding Information: This work was supported by the National Institutes of Health, R01HL090313-01, “Smoking Cessation and the Natural History of HIV-Associated Emphysema” and Award Number UL1RR025755 from the National Center For Advancing Translational Sciences. We would like to acknowledge the following people for their diligent effort on this study: Judith Harness, RN, MS (nurse-interventionist), and Karen Martin and Janice Drake (OSU Pulmonary Clinical Trials). We would like to thank the research participants for their time and commitment. Funding Information: This study was conducted as part of the Lung HIV study, a multi-site (8 sites) study funded by the National Heart, Lung, and Blood Institute (R01HL090313-01) conducted to characterize HIV-associated lung infections and complications in the era of combination ART []. Longitudinal changes in lung function among HIV-infected smokers who quit, as compared to those who continued to smoke, was the focus of our clinical center site. Our study used a one-group longitudinal design. Specific to our site, all participants were HIV-infected smokers at baseline and were exposed to intensive tobacco dependence treatment to achieve the highest number of participants who successfully quit smoking. Participants were not randomized to treatment. All participants received the most efficacious therapy available based on the USPHS Clinical Practice Guideline Treating Tobacco Use and Dependence (i.e., cognitive-behavioral therapy plus appropriate pharmacotherapy) []. Publisher Copyright: {\textcopyright} 2015, Springer Science+Business Media New York.",
year = "2016",
month = mar,
day = "1",
doi = "10.1007/s10461-015-1059-1",
language = "English (US)",
volume = "20",
pages = "608--621",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "3",
}